vimarsana.com

Page 2 - Complementary Approach News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Customer or Risk? Where Information Management Should Focus

Salivary IgG to SARS-CoV-2 after mild COVID-19

Salivary IgG to SARS-CoV-2 after mild COVID-19 A team of researchers based in Stockholm, Sweden, has demonstrated that individuals exposed to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have antibodies for the disease up to nine months after acquiring the disease, even if they displayed only mild symptoms. Concerns of COVID reinfection Symptoms of SARS-CoV-2, the underlying agent for coronavirus disease 2019 (COVID-19), vary massively amongst populations of different age groups and health conditions. Most notably, people over the age of 60, and those with underlying health conditions – predominantly lung and autoimmune – tend to suffer worse than younger individuals. Older age groups especially suffer more fatalities and more serious afflictions.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.